Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Clarivate Plc CLVT

Technology Information Technology Services
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions.... see more

Recent & Breaking News (NYSE:CLVT)

New Clarivate Report Identifies Trends in Gene Therapy Poised to Impact Patients, Payers, Regulators and Developers

PR Newswire May 2, 2023

Clarivate Report on U.S. Research Emphasizes Need for Continued International Collaboration and Domestic Regional Investment

PR Newswire April 27, 2023

Clarivate Appoints Henry Levy as President, Life Sciences & Healthcare

PR Newswire April 26, 2023

Clarivate to Report First Quarter 2023 Results on May 9, 2023

PR Newswire April 20, 2023

Clarivate Names Bar Veinstein as President, Academia & Government

PR Newswire April 19, 2023

BioWorld by Clarivate Explores the New Era of Radiopharmaceuticals and its Emergence as a Novel Cancer Therapy

PR Newswire April 13, 2023

Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent Director

PR Newswire March 23, 2023

Clarivate to Present at the BofA Securities 2023 Information & Business Services Conference on March 16

PR Newswire March 13, 2023

Clarivate Reports Fourth Quarter and Full Year 2022 Results

PR Newswire March 1, 2023

Clarivate Announces Details of its Investor Day on March 9, 2023

PR Newswire February 23, 2023

Clarivate and KAIST Innovation Strategy and Policy Institute Release Report on the Global AI Chip Innovation Landscape

PR Newswire February 22, 2023

Clarivate Names Top 100 Global Innovators 2023

PR Newswire February 16, 2023

Clarivate Adds Preprint Citation Index to the Web of Science

PR Newswire February 9, 2023

Clarivate to Report Fourth Quarter and Full Year 2022 Results on March 1, 2023

PR Newswire February 7, 2023

BioWorld by Clarivate Rethinks Obesity in New Special Investigation, Finding Fitness May Be More Linked to Health than Weight

PR Newswire February 6, 2023

Clarivate Identifies Fifteen Potential Blockbuster Drugs in Annual Drugs to Watch Report

PR Newswire January 10, 2023

Clarivate and the Chinese Academy of Sciences Release Annual Joint Report to Identify 165 Research Fronts

PR Newswire January 3, 2023

CLARIVATE ADOPTS TAX BENEFITS PRESERVATION PLAN TO PROTECT AVAILABILITY OF NET OPERATING LOSSES

PR Newswire December 22, 2022

CLARIVATE REDUCES BOARD SIZE, ENHANCING CORPORATE GOVERNANCE

PR Newswire December 20, 2022

Clarivate Expands Real World Data and Analytics Solutions with Addition of U.S. Specialty Pharmacy Data

PR Newswire December 6, 2022